Clinical Data

weight loss scale weigh measure tape obesity overweight
Biotech

Kailera reports Zepbound-rivaling weight loss in obesity phase 2

Kailera and partner Jiangsu Hengrui Pharmaceuticals linked the injectable GLP-1/GIP receptor dual agonist to 22.8% mean weight loss after 36 weeks.
Nick Paul Taylor Jan 13, 2025 10:20am
Soccer ball flying into a net scoring a goal

Pfizer's PD-1 prospect hits goal in phase 3 bladder cancer study

Jan 10, 2025 6:45am
Graphic image of an arrow nailing the bullseye of a target

Bayer’s hot flash drug hits goal in phase 3 breast cancer trial

Jan 9, 2025 7:40am
Concepts of medical examination and study of intestine microflora

MaaT's phase 3 GvHD trial hits goal, teeing up microbiome filing

Jan 9, 2025 5:18am
gold arrow pointing upward forward

Sana stock price triples after allogeneic cell therapy data drop

Jan 8, 2025 10:38am
schizophrenia mental health brain neurodegenerative

LB Pharma's twist on old Sanofi drug passes schizophrenia test

Jan 8, 2025 7:00am